共 42 条
[5]
BRITTO MR, 1992, DRUG METAB DISPOS, V20, P446
[6]
DEBRISOQUINE OXIDATION POLYMORPHISM - PHENOTYPIC CONSEQUENCES OF A 3-BASE-PAIR DELETION IN EXON 5 OF THE CYP2D6 GENE
[J].
PHARMACOGENETICS,
1993, 3 (03)
:123-130
[8]
CHAPDELAINE P, 1993, BIOTECHNIQUES, V14, P163
[9]
GENETICALLY VARIABLE METABOLISM OF ANTIDEPRESSANTS AND NEUROLEPTIC DRUGS IN MAN
[J].
PHARMACOGENETICS,
1993, 3 (02)
:61-70
[10]
GENETIC AND METABOLIC CRITERIA FOR THE ASSIGNMENT OF DEBRISOQUINE 4-HYDROXYLATION (CYTOCHROME-P4502D6) PHENOTYPES
[J].
PHARMACOGENETICS,
1991, 1 (01)
:33-41